Your browser doesn't support javascript.
loading
Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Begic, Valerija; Korac, Petra; Gasparov, Slavko; Rozman, Marija; Simicic, Petra; Zidovec-Lepej, Snjezana.
Afiliação
  • Begic V; Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.
  • Korac P; Primary School "Sesvetski Kraljevec", 10361 Sesvetski Kraljevec, Croatia.
  • Gasparov S; Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia.
  • Rozman M; Institute of Clinical Pathology and Cytology, Merkur University Hospital, 10000 Zagreb, Croatia.
  • Simicic P; Department of Pathology, Medical School Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Zidovec-Lepej S; Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
Int J Mol Sci ; 23(24)2022 Dec 09.
Article em En | MEDLINE | ID: mdl-36555277
ABSTRACT
Hodgkin lymphomas (HLs) are a heterogeneous group of lymphoid neoplasia associated with Epstein-Barr virus (EBV) infection. EBV, considered to be an important etiological co-factor in approximately 1% of human malignancies, can be classified into two genotypes based on EBNA-2, EBNA-3A and EBNA-3C sequences, and into genetic variants based on the sequence variation of the gene coding for the LMP1 protein. Here, we present the results on the distribution of EBV genotypes 1 and 2 as well as LMP1 gene variants in 50 patients with EBV-positive classical HL selected from a cohort of 289 histologically verified cases collected over a 9-year period in a tertiary clinical center in the Southeast of Europe. The population-based sequencing of the EBNA-3C gene showed the exclusive presence of EBV genotype 1 in all cHL samples. The analysis of EBV LMP1 variant distribution showed a predominance of the wild-type strain B95-8 and the Mediterranean subtype with 30 bp deletion. These findings could contribute to the understanding of EBV immunobiology in cHL as well as to the development of a prophylactic and therapeutic vaccine.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Infecções por Vírus Epstein-Barr Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Infecções por Vírus Epstein-Barr Idioma: En Ano de publicação: 2022 Tipo de documento: Article